Ansuvimab
Records for this ingredient, by country (identity only).
ATC J06BD04 · 1 markets · 2 records
US 2 records · 2 shown of 2
- 400 mg per mL / per unit basis not statedinjectionManufacturer: Catalent Indiana, LLC
- 400 mg/8 mLinjectionEbanga
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.